337 related articles for article (PubMed ID: 31942696)
1. STAT3 inhibitory stattic enhances immunogenic cell death induced by chemotherapy in cancer cells.
Jafari S; Lavasanifar A; Hejazi MS; Maleki-Dizaji N; Mesgari M; Molavi O
Daru; 2020 Jun; 28(1):159-169. PubMed ID: 31942696
[TBL] [Abstract][Full Text] [Related]
2. Silibinin induces immunogenic cell death in cancer cells and enhances the induced immunogenicity by chemotherapy.
Jafari S; Heydarian S; Lai R; Mehdizadeh Aghdam E; Molavi O
Bioimpacts; 2023; 13(1):51-61. PubMed ID: 36816998
[No Abstract] [Full Text] [Related]
3. The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma.
He Z; Jing X; Dai X; Bao L; Yang X; Xiong Y; Li M
Front Biosci (Landmark Ed); 2024 Apr; 29(4):158. PubMed ID: 38682206
[TBL] [Abstract][Full Text] [Related]
4. Oxaliplatin induces immunogenic cell death in hepatocellular carcinoma cells and synergizes with immune checkpoint blockade therapy.
Zhu H; Shan Y; Ge K; Lu J; Kong W; Jia C
Cell Oncol (Dordr); 2020 Dec; 43(6):1203-1214. PubMed ID: 32797385
[TBL] [Abstract][Full Text] [Related]
5. Formulation of Stattic as STAT3 inhibitor in nanostructured lipid carriers (NLCs) enhances efficacy of doxorubicin in melanoma cancer cells.
Mohammadian J; Mahmoudi S; Pourmohammad P; Pirouzpanah M; Salehnia F; Maroufi NF; Samadi N; Sabzichi M
Naunyn Schmiedebergs Arch Pharmacol; 2020 Dec; 393(12):2315-2323. PubMed ID: 32653978
[TBL] [Abstract][Full Text] [Related]
6. Stattic sensitizes osteosarcoma cells to epidermal growth factor receptor inhibitors via blocking the interleukin 6-induced STAT3 pathway.
Wang S; Wang Y; Huang Z; Wei H; Wang X; Shen R; Lan W; Zhong G; Lin J
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1670-1680. PubMed ID: 34693451
[TBL] [Abstract][Full Text] [Related]
7. Immunogenic death of colon cancer cells treated with oxaliplatin.
Tesniere A; Schlemmer F; Boige V; Kepp O; Martins I; Ghiringhelli F; Aymeric L; Michaud M; Apetoh L; Barault L; Mendiboure J; Pignon JP; Jooste V; van Endert P; Ducreux M; Zitvogel L; Piard F; Kroemer G
Oncogene; 2010 Jan; 29(4):482-91. PubMed ID: 19881547
[TBL] [Abstract][Full Text] [Related]
8. Stat3 inhibitor Stattic exhibits potent antitumor activity and induces chemo- and radio-sensitivity in nasopharyngeal carcinoma.
Pan Y; Zhou F; Zhang R; Claret FX
PLoS One; 2013; 8(1):e54565. PubMed ID: 23382914
[TBL] [Abstract][Full Text] [Related]
9. Targeting STAT3 enhances NDV-induced immunogenic cell death in prostate cancer cells.
Wang X; Shao X; Gu L; Jiang K; Wang S; Chen J; Fang J; Guo X; Yuan M; Shi J; Ding C; Meng S; Xu Q
J Cell Mol Med; 2020 Apr; 24(7):4286-4297. PubMed ID: 32100392
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant therapy with stattic enriches the anti-proliferative effect of doxorubicin in human ZR-75-1 breast cancer cells via arresting cell cycle and inducing apoptosis.
Khaki-Khatibi F; Ghorbani M; Sabzichi M; Ramezani F; Mohammadian J
Biomed Pharmacother; 2019 Jan; 109():1240-1248. PubMed ID: 30551374
[TBL] [Abstract][Full Text] [Related]
11. [STAT3 inhibitor Stattic induced IL-8 production and cell apotosis in THP-1 cells by activating ERK pathway].
Xiao Z; Chen M; Yang M; Chen X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2019 Jun; 35(6):498-504. PubMed ID: 31292053
[TBL] [Abstract][Full Text] [Related]
12. The copper (II) complex of salicylate phenanthroline induces immunogenic cell death of colorectal cancer cells through inducing endoplasmic reticulum stress.
Chen M; Wang D; Fan L; Niu D; Xu J; Liu Y; Liu Y
Int Immunopharmacol; 2024 May; 132():111980. PubMed ID: 38555819
[TBL] [Abstract][Full Text] [Related]
13. An "eat me" combinatory nano-formulation for systemic immunotherapy of solid tumors.
Abdel-Bar HM; Walters AA; Lim Y; Rouatbi N; Qin Y; Gheidari F; Han S; Osman R; Wang JT; Al-Jamal KT
Theranostics; 2021; 11(18):8738-8754. PubMed ID: 34522209
[No Abstract] [Full Text] [Related]
14. Identification of Nrf2/STAT3 axis in induction of apoptosis through sub-G
Tajmohammadi I; Mohammadian J; Sabzichi M; Mahmuodi S; Ramezani M; Aghajani M; Ramezani F
J Cell Biochem; 2019 Aug; 120(8):14035-14043. PubMed ID: 30993753
[TBL] [Abstract][Full Text] [Related]
15. The STAT3 inhibitor Stattic acts independently of STAT3 to decrease histone acetylation and modulate gene expression.
Poria DK; Sheshadri N; Balamurugan K; Sharan S; Sterneck E
J Biol Chem; 2021; 296():100220. PubMed ID: 33839684
[TBL] [Abstract][Full Text] [Related]
16. Combinatory effects of vaccinia virus VG9 and the STAT3 inhibitor Stattic on cancer therapy.
Yang R; Wang L; Sheng J; Huang Q; Pan D; Xu Y; Yan J; Wang X; Dong Z; Yang M
Arch Virol; 2019 Jul; 164(7):1805-1814. PubMed ID: 31087190
[TBL] [Abstract][Full Text] [Related]
17. 4-(N)-Docosahexaenoyl 2', 2'-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent.
Hufnagel S; Xu H; Colemam MF; Valdes SA; Liu KA; Hursting SD; Cui Z
Cancer Chemother Pharmacol; 2022 Jan; 89(1):59-69. PubMed ID: 34698902
[TBL] [Abstract][Full Text] [Related]
18. Crizotinib prodrug micelles co-delivered doxorubicin for synergistic immunogenic cell death induction on breast cancer chemo-immunotherapy.
Liang Q; Lan Y; Li Y; Cao Y; Li J; Liu Y
Eur J Pharm Biopharm; 2022 Aug; 177():260-272. PubMed ID: 35863668
[TBL] [Abstract][Full Text] [Related]
19. STAT3 inhibitor stattic enhances radiosensitivity in esophageal squamous cell carcinoma.
Zhang Q; Zhang C; He J; Guo Q; Hu D; Yang X; Wang J; Kang Y; She R; Wang Z; Li D; Huang G; Ma Z; Mao W; Zhou X; Xiao C; Sun X; Ma J
Tumour Biol; 2015 Mar; 36(3):2135-42. PubMed ID: 25492480
[TBL] [Abstract][Full Text] [Related]
20. STAT3/5 Inhibitors Suppress Proliferation in Bladder Cancer and Enhance Oncolytic Adenovirus Therapy.
Hindupur SV; Schmid SC; Koch JA; Youssef A; Baur EM; Wang D; Horn T; Slotta-Huspenina J; Gschwend JE; Holm PS; Nawroth R
Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32046095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]